Rouh‐Mei Hu

486 total citations
23 papers, 369 citations indexed

About

Rouh‐Mei Hu is a scholar working on Molecular Biology, Ecology and Information Systems and Management. According to data from OpenAlex, Rouh‐Mei Hu has authored 23 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Ecology and 3 papers in Information Systems and Management. Recurrent topics in Rouh‐Mei Hu's work include Bacteriophages and microbial interactions (3 papers), Biomedical Text Mining and Ontologies (3 papers) and RNA and protein synthesis mechanisms (3 papers). Rouh‐Mei Hu is often cited by papers focused on Bacteriophages and microbial interactions (3 papers), Biomedical Text Mining and Ontologies (3 papers) and RNA and protein synthesis mechanisms (3 papers). Rouh‐Mei Hu collaborates with scholars based in Taiwan, United States and France. Rouh‐Mei Hu's co-authors include Jeffrey J. P. Tsai, Jeng‐Wei Lu, Jan‐Gowth Chang, Kun‐Tu Yeh, Lohanathan Bharathi Priya, Rathinasamy Baskaran, Marc Uzan, Wei‐Wen Su, Balamuralikrishnan Balasubramanian and Chih‐Yang Huang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Rouh‐Mei Hu

21 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rouh‐Mei Hu Taiwan 12 200 75 68 51 48 23 369
Huiming Peng China 13 304 1.5× 87 1.2× 22 0.3× 98 1.9× 23 0.5× 33 540
Wenhao Shi China 11 246 1.2× 95 1.3× 14 0.2× 39 0.8× 16 0.3× 27 463
Leonard A. Daly United Kingdom 8 228 1.1× 24 0.3× 14 0.2× 25 0.5× 32 0.7× 18 389
Chuan-Hsiung Chang Taiwan 12 401 2.0× 152 2.0× 24 0.4× 80 1.6× 131 2.7× 17 668
Yuhang Wang China 12 309 1.5× 79 1.1× 32 0.5× 80 1.6× 21 0.4× 56 527
Gift Nyamundanda United Kingdom 7 123 0.6× 80 1.1× 12 0.2× 16 0.3× 12 0.3× 16 278
Zhi‐Song Zhang China 14 251 1.3× 46 0.6× 9 0.1× 99 1.9× 27 0.6× 32 486
Zhigang Hu China 14 177 0.9× 83 1.1× 6 0.1× 69 1.4× 94 2.0× 47 448
Christopher E. Hart United States 14 966 4.8× 28 0.4× 18 0.3× 60 1.2× 80 1.7× 28 1.1k
Patricia Rodriguez‐Tomé United Kingdom 9 491 2.5× 132 1.8× 14 0.2× 110 2.2× 78 1.6× 23 713

Countries citing papers authored by Rouh‐Mei Hu

Since Specialization
Citations

This map shows the geographic impact of Rouh‐Mei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rouh‐Mei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rouh‐Mei Hu more than expected).

Fields of papers citing papers by Rouh‐Mei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rouh‐Mei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rouh‐Mei Hu. The network helps show where Rouh‐Mei Hu may publish in the future.

Co-authorship network of co-authors of Rouh‐Mei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Rouh‐Mei Hu. A scholar is included among the top collaborators of Rouh‐Mei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rouh‐Mei Hu. Rouh‐Mei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Rouh‐Mei, et al.. (2023). CA125 for the Diagnosis of Advanced Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis. Cancers. 15(3). 813–813. 3 indexed citations
2.
Priya, Lohanathan Bharathi, Balamuralikrishnan Balasubramanian, Balamurugan Shanmugaraj, et al.. (2022). Therapeutic Potential of the Medicinal Plant Tinospora cordifolia–Minireview. Phyton. 91(6). 1129–1140. 6 indexed citations
3.
Priya, Lohanathan Bharathi, Chih‐Yang Huang, Rouh‐Mei Hu, Balamuralikrishnan Balasubramanian, & Rathinasamy Baskaran. (2021). An updated review on pharmacological properties of neferine—A bisbenzylisoquinoline alkaloid from Nelumbo nucifera. Journal of Food Biochemistry. 45(12). e13986–e13986. 38 indexed citations
5.
Shanmugaraj, Balamurugan, Lohanathan Bharathi Priya, B. Mahalakshmi, et al.. (2020). Bacterial and viral vectors as vaccine delivery vehicles for breast cancer therapy. Life Sciences. 250. 117550–117550. 29 indexed citations
6.
Tsai, Jeffrey J. P., et al.. (2018). Stratification of Human Gut Microiome and Building a SVM-Based Classifier. 19. 14–17. 2 indexed citations
7.
Hu, Rouh‐Mei, et al.. (2017). Extracting the Co-occurrences of DNA Maximal Repeats in both Human and Viruses. 125. 106–111. 2 indexed citations
8.
Tsai, Yi‐Lin, Po‐Ren Hsueh, Ming‐Che Liu, et al.. (2015). Overexpression of an Outer Membrane Protein Associated with Decreased Susceptibility to Carbapenems in Proteus mirabilis. PLoS ONE. 10(3). e0120395–e0120395. 9 indexed citations
9.
Lin, Chien‐Yu, et al.. (2014). Association Study Between Macrophage Migration Inhibitory Factor-173 Polymorphism and Acute Myeloid Leukemia in Taiwan. Cell Biochemistry and Biophysics. 70(2). 1159–1165. 11 indexed citations
10.
Chen, William Tzu‐Liang, Ching‐Tien Peng, Rouh‐Mei Hu, et al.. (2014). Association Between Genetic Polymorphism of the MIF Gene and Colorectal Cancer in Taiwan. Journal of Clinical Laboratory Analysis. 29(4). 268–274. 11 indexed citations
11.
Lu, Jeng‐Wei, Yueh‐Min Lin, Jan‐Gowth Chang, et al.. (2013). Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. Medical Oncology. 30(1). 379–379. 55 indexed citations
12.
Lu, Jeng‐Wei, Jan‐Gowth Chang, Kun‐Tu Yeh, et al.. (2012). Increased expression of PRL-1 protein correlates with shortened patient survival in human hepatocellular carcinoma. Clinical & Translational Oncology. 14(4). 287–293. 12 indexed citations
13.
Lu, Jeng‐Wei, et al.. (2011). Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochemica. 113(8). 833–838. 59 indexed citations
14.
Hecht, David, Charles C. N. Wang, Rouh‐Mei Hu, & Jeffrey J. P. Tsai. (2011). Molecular Modeling Studies of AmpR Mediated AmpC ß-Lactamase Repression. 17. 195–200. 1 indexed citations
15.
Tai, Wei‐Liang, et al.. (2011). Blood Cell Image Classification Based on Hierarchical SVM. 129–136. 30 indexed citations
16.
Lu, Jeng‐Wei, et al.. (2010). Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma. Medical Oncology. 28(S1). 239–245. 14 indexed citations
17.
Wang, Shu, Rouh‐Mei Hu, Catherine Hsiao, et al.. (2008). Using SCDL for Integrating Tools and Data for Complex Biochemical Applications. 1(2). 291–308. 1 indexed citations
18.
Hu, Rouh‐Mei, Teh‐Yuan Chow, Juey‐Wen Lin, et al.. (2007). Comparison of Genomes of Three Xanthomonas oryzae Bacteriophages. BMC Genomics. 8(1). 442–442. 26 indexed citations
19.
Lebars, Isabelle, Rouh‐Mei Hu, Jean‐Yves Lallemand, Marc Uzan, & François Bontems. (2001). Role of the Substrate Conformation and of the S1 Protein in the Cleavage Efficiency of the T4 Endoribonuclease RegB. Journal of Biological Chemistry. 276(16). 13264–13272. 23 indexed citations
20.
Sanson, Bénédicte, et al.. (2000). Endoribonuclease RegB from bacteriophage T4 is necessary for the degradation of early but not middle or late mRNAs11Edited by M. Yaniv. Journal of Molecular Biology. 297(5). 1063–1074. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026